digital currency ranking list, Knowledge graph

In today's era of rapid development of science and technology, human beings are facing unprecedented competitive pressure from AI (artificial intelligence) and humanoid robots. The intensification of this competition is changing our social pattern in many aspects, one of which is the demand for biomedicine in neurosurgery.First, the status quo of human competition with AI and humanoid robotsIv. Countermeasures and future prospects

First, the status quo of human competition with AI and humanoid robotsCompetition between human and AI and humanoid robots: the growth of biomedical demand in neurosurgery.In this process, it is also crucial to cultivate professional talents. It is necessary to set up more specialties and courses related to neurosurgery and biomedicine in universities and scientific research institutions to attract more students to devote themselves to the research in this field. At the same time, it is necessary to strengthen international cooperation and exchanges, introduce advanced foreign technologies and concepts, and improve the research level in this field in China.

(A) the increase of brain diseasesThis competitive pressure has not only brought about a crisis in employment, but also had an impact on psychology and physiology. From the psychological point of view, under the pressure of long-term competition with machines, human beings are prone to negative emotions such as anxiety and inferiority. The accumulation of these emotions may lead to mental health problems, such as depression and neurasthenia. Physiologically speaking, in order not to be eliminated in the competition, people are often overworked and in a state of tension for a long time, which will affect the nervous system function of the human body. For example, long-term stress may lead to headaches, insomnia and other problems, and even serious organic diseases of the nervous system.In order to meet the growing demand for biomedicine in neurosurgery, the research and development direction needs to be more precise and diversified. On the one hand, it is necessary to increase the research on the pathogenesis of brain diseases in order to develop more targeted drugs. For example, in-depth study of the causes of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, so as to find effective treatment drugs. On the other hand, we should actively explore the combination of biotechnology and other technologies, such as the combination of nanotechnology and neurosurgery biomedicine, which can improve the targeting and therapeutic effect of drugs.